Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Metabolon expands with new China lab
May 2018
SHARING OPTIONS:

RESEARCH TRIANGLE PARK, N.C.—Metabolon Inc.’s joint metabolomics laboratory with Zhejiang Dian Diagnostics (DIAN) has received full validation in running Metabolon’s proprietary metabolomics platform. The joint lab has begun processing client samples under an exclusive licensing agreement with Metabolon, and Hangzhou Calibra Diagnostics Co. Ltd., a majority-owned subsidiary of DIAN, will stand as the exclusive partner for providing Metabolon’s metabolomics services and commercializing its technology in China.
 
“Launching our global metabolomics platform in China allows us to better serve current and future customers in this significant, growing market,” said Metabolon CEO Dr. John Ryals. “Calibra has done an outstanding job establishing the laboratory, validating the platform and preparing its marketing team for this day. We look forward to a successful relationship as they expand our service offerings for research applications in clinical research, health management, traditional Chinese medicine, pharmaceuticals, consumer goods and agriculture, as well as supporting large-cohort population studies throughout the Chinese market.”

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2018 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.